RESUMO
The susceptibility trends for Bacteroides fragilis and related species against various antibiotics were determined using data from 3 years of surveillance (2010-2012) on 779 isolates referred by 7 medical centers. The antibiotic test panel included imipenem, ertapenem, meropenem, ampicillin-sulbactam, piperacillin-tazobactam, cefoxitin, clindamycin, moxifloxacin, tigecycline, linezolid, chloramphenicol and . MICs were determined using the agar dilution CLSI reference method. Carbapenem resistance remained low (range 1.1%-2.5%) and unchanged from 2008 to 9 through 2010-2012. Resistance also remained low to the beta-lactam/beta-lactamase inhibitor combinations (1.1%-4.4%). While resistance to clindamycin and moxifloxacin remained high; rates were lower for B. fragilis in 2010-12 (24% and 19% respectively) compared to the earlier time frame of 2008-9 (29% and 35% respectively for the earlier time frame). There were notable species and resistance associations which have been demonstrated previously. No resistance to metronidazole or chloramphenicol resistance was seen. These data demonstrate the continued variability in resistance among Bacteroides and Parabacteroides species, but do demonstrate that carbapenems and beta-lactam/beta-lactamase inhibitor combinations remain very active throughout the United States.
Assuntos
Anti-Infecciosos/farmacologia , Infecções por Bacteroides/tratamento farmacológico , Bacteroidetes/efeitos dos fármacos , Carbapenêmicos/farmacologia , Resistência Microbiana a Medicamentos , Inibidores de beta-Lactamases/farmacologia , Bacteroides/efeitos dos fármacos , Infecções por Bacteroides/microbiologia , Bacteroides fragilis/efeitos dos fármacos , Humanos , Testes de Sensibilidade Microbiana , Ácido Penicilânico/análogos & derivados , Ácido Penicilânico/farmacologia , Piperacilina/farmacologia , Combinação Piperacilina e Tazobactam , Estados UnidosRESUMO
OBJECTIVES: The aim of this study was to evaluate the susceptibilities of Clostridium difficile isolates to cadazolid, a novel antibiotic for the treatment of C. difficile infection. METHODS: Ribotyping and susceptibilities were determined for C. difficile isolates from a multicentre, double-blind, Phase 2 study of oral cadazolid in patients with C. difficile infection (NCT01222702, ClinicalTrials.gov; EudraCT 2010-020941-29, European Clinical Trials Database). Patients were randomized to receive 250, 500 or 1000 mg of cadazolid twice daily or 125 mg of vancomycin four times daily, for 10 days. MICs of cadazolid, vancomycin, fidaxomicin, linezolid and moxifloxacin were determined at baseline for all patients and post-baseline for patients with clinical failure or recurrence, using the agar dilution method. RESULTS: Seventy-eight of 84 patients had an evaluable toxigenic C. difficile isolate at baseline. The most frequent PCR ribotype was 027 (15.4%). Cadazolid MICs for baseline isolates (including epidemic strain 027) ranged from 0.06 to 0.25 mg/L. Baseline cadazolid MICs were similar to those of fidaxomicin and lower than those of vancomycin, linezolid and moxifloxacin. For each clinical outcome group (clinical cure, clinical failure, sustained clinical response and clinical failure or recurrence), the baseline cadazolid MIC range was 0.06-0.25 mg/L. Mean (min-max) cadazolid faecal concentration (µg/g) on day 5 was 884 (101-2710), 1706 (204-4230) and 3226 (1481-12â600) for the doses 250, 500 and 1000 mg, respectively. CONCLUSIONS: For all cadazolid doses, the faecal concentration was in excess of several thousand-fold the MIC90 for C. difficile. The MIC of cadazolid for all C. difficile isolates, including epidemic strains, was low and in the same narrow range regardless of treatment outcome.
Assuntos
Antibacterianos/administração & dosagem , Clostridioides difficile/efeitos dos fármacos , Infecções por Clostridium/tratamento farmacológico , Infecções por Clostridium/microbiologia , Oxazolidinonas/administração & dosagem , Vancomicina/administração & dosagem , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Antibacterianos/farmacologia , Clostridioides difficile/classificação , Clostridioides difficile/genética , Clostridioides difficile/isolamento & purificação , Método Duplo-Cego , Feminino , Humanos , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Oxazolidinonas/farmacologia , Ribotipagem , Vancomicina/farmacologia , Adulto JovemRESUMO
The susceptibility trends for the species of the Bacteroides fragilis group against various antibiotics were determined using data from 4 years [2006-2009] on 1957 isolates referred by 8 medical centers participating in a National Survey for the Susceptibility of B. fragilis. The antibiotic test panel included doripenem, ertapenem, imipenem, meropenem, ampicillin:sulbactam, piperacillin:tazobactam, cefoxitin, clindamycin, moxifloxacin, tigecycline, chloramphenicol and metronidazole. MICs were determined using agar dilution methods following CLSI recommendations. Genetic analysis of isolates from 2008 with elevated MICs (>2 µg/mL) to one or more of the carbapenems to detect presence of the cfiA gene was performed using PCR methodology. The results showed an increase in the resistance rates to the ß-lactam antibiotics. High resistance rates were seen for clindamycin and moxifloxacin (as high as 60% for clindamycin and >80% for moxifloxacin), with relatively stable low resistance (5.4%) for tigecycline. For carbapenems, resistance in B. fragilis was 1.1%-2.5% in 2008-9. One isolate resistant to metronidazole (MIC 32 µg/mL) was observed as well as isolates with elevated MICs to chloramphenicol (16 µg/mL). Genetic analysis indicated that the cfiA gene was present in some but not all of the isolates with high MICs to the carbapenems. These data indicate that there continue to be changes in susceptibility over time, and that resistance can be seen among the carbapenems. High antibiotic resistance rates tend to be associated with specific species.
Assuntos
Bacteroides fragilis/efeitos dos fármacos , Bacteroides fragilis/genética , Carbapenêmicos/farmacologia , Antibacterianos/farmacologia , Proteínas de Bactérias/genética , Bacteroides fragilis/isolamento & purificação , Resistência Microbiana a Medicamentos , Genes Bacterianos , Humanos , Testes de Sensibilidade Microbiana/métodos , beta-Lactamases/genéticaRESUMO
A multilaboratory study compared the growth of 30 fastidious anaerobes, using 5 different agar media: Wilkins-Chalgren (WC), WC with either whole or laked sheep blood, and Brucella supplemented with vitamin K(1) and hemin and either laked or whole sheep blood. The media were compared for quality and quantity of growth. Experiments were conducted either entirely in an anaerobic chamber or inoculated in ambient air with anaerobic incubation. The results showed that (1) any medium plus whole or laked blood was better than unsupplemented WC, (2) whole blood and laked blood additives gave similar results, (3) supplemented Brucella with whole or laked blood was superior to WC and WC with whole or laked blood, and (4) anaerobic and aerobic inoculation with anaerobic incubation gave similar results. Brucella agar supplemented with whole or laked blood supports the growth of fastidious anaerobic species better than the WC agars do.
Assuntos
Bactérias Anaeróbias/crescimento & desenvolvimento , Meios de Cultura , Bactérias Anaeróbias/efeitos dos fármacos , Sangue , Meios de Cultura/farmacologia , Hemina/farmacologia , Humanos , Vitamina K 1/farmacologiaRESUMO
A 5-laboratory study was performed that used the National Committee for Clinical Laboratory Standards (NCCLS) reference agar dilution method with 3 media formulations to determine whether the use of different media would affect minimum inhibitory concentration (MIC) results. Wilkins-Chalgren, Brucella-based blood agar (BRU), and Wilkins-Chalgren agar plus blood (WCB) and 6 antibiotics (clindamycin, cefoxitin, ceftizoxime, piperacillin, metronidazole, and trovafloxacin) were evaluated with 58 isolates. The MIC values were compared, and a significant correlation of >0.80 was demonstrated for all media and each antibiotic/organism group. The cumulative rate of errors for all antibiotics was 0.1%. These data indicate that a change in the NCCLS reference medium for testing of anaerobic bacteria susceptibility to either BRU or WCB will not affect the MIC results for the antibiotics and organisms evaluated.
Assuntos
Bactérias Anaeróbias , Meios de Cultura , Testes de Sensibilidade Microbiana/métodos , Antibacterianos/farmacologia , Bactérias Anaeróbias/efeitos dos fármacos , Bactérias Anaeróbias/isolamento & purificação , Sangue , Hemina/farmacologia , Humanos , Vitamina K 1/farmacologiaRESUMO
The results of a multicenter US survey using the National Committee for Clinical Laboratory Standards currently recommended methodology for measuring in vitro susceptibility of 2673 isolates of Bacteroides fragilis group species were compared from 1997 to 2000. The test panel consisted of 14 antibiotics: 3 carbapenems, 3 beta-lactam-beta-lactamase inhibitors, 3 cephamycins, 2 fluoroquinolones, clindamycin, chloramphenicol, and metronidazole. Declines in the geometric mean minimum inhibitory concentrations were seen with imipenem, meropenem, ampicillin-sulbactam, and the cephamycins. Increased geometric means were observed with the fluoroquinolones and were usually accompanied by an increase in resistance rates. Bacteroides distasonis shows the highest resistance rates among beta-lactam antibiotics, whereas Bacteroides vulgatus shows the highest resistance levels among fluoroquinolones. B. fragilis shows the lowest resistance rates for all antibiotics. All strains were susceptible to chloramphenicol and metronidazole concentrations <8 microgram/mL. The data underscore the need for species identification and continued surveillance to monitor resistance patterns.
Assuntos
Antibacterianos/farmacologia , Bacteroides fragilis/efeitos dos fármacos , Coleta de Dados , Farmacorresistência Bacteriana/fisiologia , Humanos , Testes de Sensibilidade Microbiana/normasRESUMO
There have been few reports on Branhamella catarrhalis as a nosocomial pathogen, and no risk factors for nosocomial infection have been identified. We report 11 cases (mean age 22 months) of nosocomial Branhamella catarrhalis respiratory tract infection in a paediatric intensive care unit (PICU) over a two-year period. There were 2 cases of pneumonia and 9 cases of bronchitis. Branhamella catarrhalis was the sole isolate recovered in 6 cases and was associated with other respiratory pathogens in 5 cases. A case-control study with two age-matched controls per patient (mean age 24.1 months) was undertaken to identify potential risk factors for infection; risk factors identified were the presence of an endotracheal tube (p less than 0.02) and frequent endotracheal tube suction (p less than 0.05). Five of 6 tested strains from PICU patients produced beta-lactamase. DNA preparations of 4 B. catarrhalis isolates from PICU patients revealed no plasmids. B. catarrhalis should be considered a potential nosocomial pathogen.
Assuntos
Infecção Hospitalar/etiologia , Moraxella catarrhalis , Infecções Respiratórias/etiologia , Boston , Criança , Pré-Escolar , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/terapia , Feminino , Humanos , Lactente , Unidades de Terapia Intensiva Pediátrica , Intubação Intratraqueal/efeitos adversos , Masculino , Infecções Respiratórias/epidemiologia , Infecções Respiratórias/terapia , Fatores de Risco , Sucção/efeitos adversosRESUMO
To examine whether the gut is a source of infection in acute pancreatitis, bacterial translocation and alterations of intestinal microecology and morphology were studied in 16 dogs. Dogs were colonized with a strain of Escherichia coli (E. coli 6938K) bearing the plasmid pUC4K, which confers kanamycin resistance. In eight dogs (group I), pancreatitis was induced by sodium taurocholate/trypsin injection. Eight other dogs (group II) underwent laparotomy only. The pancreas, mesenteric lymph nodes, peritoneal fluid, liver, and spleen were harvested 7 days later for culturing and histologic analysis. Identification of E. coli 6938K was accomplished by plasmid DNA analysis. Group I dogs had severe pancreatitis and ischemic changes in small bowel mucosa. Group II dogs had no changes. Translocation to the pancreas occurred in five dogs and to mesenteric lymph nodes in six dogs with pancreatitis. No translocation occurred in group II dogs (p < 0.05). In addition to E. coli 6938K, other gram-negative kanamycin-resistant species were isolated, including E. coli (other than 6938K) and Enterobacter cloacae. Enteric origin of these strains was confirmed by antibiography and plasmid DNA analysis. No overgrowth of cecal gram-negative bacteria was found. This study suggests that the gut is a primary source of infection in pancreatitis and that ischemic damage of intestinal mucosa may promote bacterial translocation.
Assuntos
Ceco/microbiologia , Escherichia coli/fisiologia , Pancreatite/microbiologia , Fatores R , Doença Aguda , Animais , Líquido Ascítico/microbiologia , Cães , Escherichia coli/isolamento & purificação , Mucosa Intestinal/microbiologia , Resistência a Canamicina/genética , Fígado/microbiologia , Linfonodos/microbiologia , Pâncreas/microbiologia , Pancreatite/induzido quimicamente , Baço/microbiologiaRESUMO
A strain of Staphylococcus epidermidis was transduced to tobramycin resistance and all transductants were also resistant to kanamycin and neomycin. Results of curing studies also indicated that these resistances were controlled by a single determinant on a plasmid. Agarose gel electrophoresis of the plasmid DNA from parent, cured, and transduced strains showed a single plasmid was responsible and its molecular weight was calculated to be 2.85 x 10(6). Attempts to determine other properties of the organism controlled by this plasmid were unsuccessful.
Assuntos
Antibacterianos/farmacologia , Canamicina/farmacologia , Neomicina/farmacologia , Fatores R , Staphylococcus/efeitos dos fármacos , Tobramicina/farmacologia , Cinética , Peso Molecular , Staphylococcus/genéticaAssuntos
Doenças das Glândulas Salivares/diagnóstico , Sialadenite/diagnóstico , Doença Aguda , Doença da Arranhadura de Gato/diagnóstico , Doença Crônica , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Humanos , Inflamação/etiologia , Masculino , Micoses/diagnóstico , Radioterapia/efeitos adversos , Cálculos dos Ductos Salivares/diagnóstico , Cálculos dos Ductos Salivares/terapia , Sarcoidose/diagnóstico , Sialadenite/etiologia , Sialadenite/terapia , Tuberculose Bucal/diagnóstico , Tuberculose Bucal/terapia , Viroses/diagnósticoRESUMO
The susceptibility trends for the species of the Bacteroides fragilis group against various antibiotics from 1997 to 2004 were determined by using data for 5,225 isolates referred by 10 medical centers. The antibiotic test panel included ertapenem, imipenem, meropenem, ampicillin-sulbactam, piperacillin-tazobactam, cefoxitin, clindamycin, moxifloxacin, tigecycline, chloramphenicol, and metronidazole. From 1997 to 2004 there were decreases in the geometric mean (GM) MICs of imipenem, meropenem, piperacillin-tazobactam, and cefoxitin for many of the species within the group. B. distasonis showed the highest rates of resistance to most of the beta-lactams. B. fragilis, B. ovatus, and B. thetaiotaomicron showed significantly higher GM MICs and rates of resistance to clindamycin over time. The rate of resistance to moxifloxacin of B. vulgatus was very high (MIC range for the 8-year study period, 38% to 66%). B. fragilis, B. ovatus, and B. distasonis and other Bacteroides spp. exhibited significant increases in the rates of resistance to moxifloxacin over the 8 years. Resistance rates and GM MICs for tigecycline were low and stable during the 5-year period over which this agent was studied. All isolates were susceptible to chloramphenicol (MICs < 16 microg/ml). In 2002, one isolate resistant to metronidazole (MIC = 64 microg/ml) was noted. These data indicate changes in susceptibility over time; surprisingly, some antimicrobial agents are more active now than they were 5 years ago.
Assuntos
Antibacterianos/farmacologia , Bacteroides fragilis/efeitos dos fármacos , Bacteroides/efeitos dos fármacos , Farmacorresistência Bacteriana , Testes de Sensibilidade Microbiana , Fatores de Tempo , Estados UnidosRESUMO
Bacteroides fragilis is an important anaerobic pathogen accounting for up to 10% of bacteremias in adult patients. Enterotoxin producing B. fragilis (ETBF) strains have been identified as enteric pathogens of children and adults. In order to further characterize the B. fragilis pathogenicity island (BfPAI) and using PCR assays for bft- and mpII-metalloprotease genes, we determined the frequency of B. fragilis strains with pattern I (containing the BfPAI and its flanking region), pattern II (lacking both the BfPAI and the flanking region), and pattern III (lacking the BfPAI but containing the flanking region) in 63 blood culture isolates. The results were compared to 197 B. fragilis isolates from different clinical sources. We found 19% of blood culture isolates were pattern I (ETBF), 43% were pattern II (NTBF) and 38% were pattern III (NTBF). Comparatively, B. fragilis isolates from other clinical sources were 10% pattern I, 47% pattern II and 43% pattern III. This suggests that the pathogenicity island and the flanking elements may be general virulence factors of B. fragilis.
Assuntos
Bacteriemia/microbiologia , Infecções por Bacteroides/microbiologia , Bacteroides fragilis/genética , Bacteroides fragilis/patogenicidade , Ilhas Genômicas/genética , Toxinas Bacterianas/genética , Bacteroides fragilis/classificação , Bacteroides fragilis/isolamento & purificação , Sequência de Bases/genética , Impressões Digitais de DNA , DNA Bacteriano/química , Desoxirribonucleases/química , Humanos , Metaloendopeptidases/genética , Metaloproteases/genética , Dados de Sequência Molecular , Reação em Cadeia da Polimerase/métodos , Análise de Sequência de DNARESUMO
Clostridium clostridioforme shows much variability in phenotypic and antimicrobial susceptibility tests, suggesting it may be more than a single species even though all strains share unique morphology. This study was designed to determine if there are multiple species and, if so, to demonstrate the differences that exist between them. A total of 107 strains of C. clostridioforme were investigated by sequencing of the 16S rRNA gene, phenotypic studies, and antimicrobial susceptibility testing. In addition, clinical data from patients whose infections yielded an organism identified as C. clostridioforme was reviewed. Data from the above studies revealed three principal species in what has been called C. clostridioforme: Clostridium bolteae, C. clostridioforme, and Clostridium hathewayi. Each species may be distinguished by certain phenotypic tests. All three species were involved in infections, including bacteremia. C. clostridioforme appears to be associated with more serious or invasive human infections than the other two species in the group. Resistance to penicillin G is common and is due to beta-lactamase production. Resistance to clindamycin and moxifloxacin is also seen. The three species differ in terms of virulence and antimicrobial resistance. "C. clostridioforme" actually represents three distinct species that are different in terms of 16S rRNA sequences, phenotypic characteristics, and antimicrobial susceptibility. It is important for microbiology laboratories to distinguish between these species and for clinicians to be aware of the differences between them.
Assuntos
Antibacterianos/farmacologia , Clostridium/classificação , Clostridium/efeitos dos fármacos , Clostridium/genética , Clostridium/patogenicidade , Infecções por Clostridium/microbiologia , Farmacorresistência Bacteriana , Humanos , Fenótipo , RNA Ribossômico 16S/genéticaRESUMO
The susceptibility of isolates of the Bacteroides fragilis group to eight antibiotics was determined by the agar dilution method on three media. At intermediate breakpoints established by the National Committee for Clinical Laboratory Standards (NCCLS), only minimal differences in the susceptibility of each species to any of the antibiotics were documented among the three media. At NCCLS susceptible breakpoints, greater differences among media were found for cefoxitin and cefotetan than for the other drugs tested. Only minimal differences among the three media were evident in comparisons of MIC50, MIC90, and geometric mean MIC values for all antibiotics tested. Thus, use of any one of these three media does not significantly affect agar-dilution MIC results for the B. fragilis group.
Assuntos
Antibacterianos/farmacologia , Bacteroides fragilis/efeitos dos fármacos , Meios de Cultura , Testes de Sensibilidade Microbiana , Bacteroides fragilis/isolamento & purificação , HumanosRESUMO
Conjugal transposons play an important role in the dissemination of antibiotic resistance determinants in the streptococci and have been postulated to exist in Bacteroides fragilis. To investigate the presence of conjugal transposons in B. fragilis, we employed a Tra- derivative of the transfer factor pBFTM10 contained in the chimeric plasmid pGAT400 delta BglII. We attempted to restore transferability to this plasmid from a series of transconjugants generated by crossing B. fragilis TMP230 containing the TET transfer factor with B. fragilis TM4000, a standard recipient. Transconjugant TM4.2321 transferred pGAT400 delta BglII to Escherichia coli HB101 at almost the same frequency as did the Tra+ parental plasmid, pGAT400. Analysis of the transferred plasmids revealed the presence of 9.6 kilobases of additional DNA in every case but at different positions in independent isolates. The presence of this DNA, designated Tn4399, allowed the pGAT400 delta BglII derivatives to retransfer from the TM4000 background to B. fragilis or E. coli recipients. DNA hybridization studies demonstrated the presence of one copy of Tn4399 in TMP230 and three copies at new sites in TM4.2321. Tn4399 is a new B. fragilis transposon with unique transfer properties that may play a role in the dissemination of drug resistance genes. It differs from previously described conjugal transposons by its ability to mobilize nonconjugal plasmids in cis.
Assuntos
Bacteroides fragilis/genética , Conjugação Genética , Elementos de DNA Transponíveis , Deleção Cromossômica , Sondas de DNA , DNA Bacteriano , Escherichia coli/genética , Genes Bacterianos , Vetores Genéticos , Mutação , Plasmídeos , TransfecçãoRESUMO
The in vitro activity of early fluoroquinolone antibodies--including ciprofloxacin, ofloxacin, fleroxacin, pefloxacin, enoxacin, and lomefloxacin--against most anaerobes has been limited, a characteristic making them poor choices as antianaerobic agents. Newer fluoroquinolones, including levofloxacin, sparfloxacin, and grepafloxacin, have moderate activity against anaerobes, including the Bacteroides fragilis group as well as Clostridium, Peptostreptococcus, Prevotella, and Fusobacterium species. Fluoroquinolones that demonstrate the greatest activity against the B. fragilis group and other anaerobes include DU-6859a, clinafloxacin, and the related naphthyridone, trovafloxacin. There has been wide variation in the susceptibility results among different studies testing the same antibiotic; such variation may be due in part to the use of different methodologies, inoculum sizes, and testing media. In a direct comparison of susceptibility findings for ciprofloxacin, ofloxacin, and levofloxacin in three different media, we have determined that twofold dilution differences in minimum inhibitory concentration (MIC) values (MIC90, mode MIC, and geometric mean MIC) may occur in association with the choice of testing media. Thus, testing media should be considered when comparing results of different studies on the susceptibility of anaerobes to fluoroquinolones.
Assuntos
Anti-Infecciosos/farmacologia , Bactérias Anaeróbias/efeitos dos fármacos , Fluoroquinolonas , Testes de Sensibilidade Microbiana/métodos , Bactérias Anaeróbias/isolamento & purificação , Meios de Cultura , Resistência Microbiana a Medicamentos , Estudos de Avaliação como Assunto , Humanos , Técnicas In Vitro , Levofloxacino , Naftiridinas/farmacologia , Ofloxacino/farmacologia , Piperazinas/farmacologia , Quinolonas/farmacologia , Estados UnidosRESUMO
Agar dilution testing was used to compare the in vitro activities of trovafloxacin and ofloxacin, ciprofloxacin, imipenem, metronidazole, and clindamycin against 585 anaerobes. The activity of trovafloxacin was superior to those of ofloxacin and ciprofloxacin, with 94%, 91%, 96%, 100%, 90%, and 100% inhibition of Bacteroides fragilis, non-fragilis Bacteroides species, Peptostreptococcus magnus/Peptostreptococcus micros, Clostridium perfringens, Prevotella bivia/Prevotella disiens, and Fusobacterium species, respectively, at a breakpoint of 2 micrograms/mL. Trovafloxacin was more active than clindamycin against most anaerobes and slightly less active than imipenem and metronidazole. Different testing media, which were compared side by side, did affect the in vitro activities of trovafloxacin, ofloxacin, and ciprofloxacin but did not affect those of the other antibiotics. Testing with supplemented brain-heart infusion agar demonstrated lower minimum inhibitory concentrations than did testing with Wilkins-Chalgren agar and supplemented brucella agar. The activity of trovafloxacin was twofold lower when the pH of the testing media was adjusted to 6.0 than when the pH of the testing media was adjusted to 7.0 or 7.5.
Assuntos
Anti-Infecciosos/farmacologia , Bactérias Anaeróbias/efeitos dos fármacos , Fluoroquinolonas , Testes de Sensibilidade Microbiana/métodos , Naftiridinas/farmacologia , Bactérias Anaeróbias/isolamento & purificação , Ciprofloxacina/farmacologia , Clindamicina/farmacologia , Meios de Cultura/química , Resistência Microbiana a Medicamentos , Humanos , Concentração de Íons de Hidrogênio , Imipenem/farmacologia , Técnicas In Vitro , Metronidazol/farmacologia , Ofloxacino/farmacologiaRESUMO
Plasmid profiles of cultures of Staphylococcus epidermidis obtained by agarose gel electrophoresis were used, in conjunction with phage typing, biotyping, and antibiograms, in epidemiologic studies of infections in neonates and patients with cancer. In some cases, patients had cultures that were lysed by a single phage, belonged to the same biotype, and had identical antibiograms, but had distinctly different plasmid profiles. In other instances, almost identical plasmid profiles were observed in cultures lysed by a single phage, belonging to the same biotype, and with markedly different antibiograms. The plasmid profile technique was valuable in detecting distinct strains of S. epidermidis, and its use could be helpful in epidemiologic studies of infections by other organisms.